We found a trend towards decreased IL12B(p40) and a significant downregulation of IL12A(p35) expression in the TU region of both ADC and SCC patients (Fig. S2B, C), indicating an inhibition of IL12, at least on mRNA level, in the TU region of NSCLC patients. This evidence concerns the gene IL12B and non-small cell lung carcinoma.